kallikrein-2 inhibitors (Dyax)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namekallikrein-2 inhibitors (Dyax)
Drug Alias NameDX-1336DX-1337
ClassificationSmall molecules
Mechanisms of ActionKallikrein 2 inhibitors
TargetsKallikrein 2
Therapy Area/IndicationsNeoplasm MetastasisProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDyax Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDyax Corp
Active IndicationsN/A
Inactive IndicationsNeoplasm MetastasisProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A